Previous 10 | Next 10 |
2023-05-09 07:03:13 ET Esperion Therapeutics press release ( NASDAQ: ESPR ): Q1 GAAP EPS of -$0.79 misses by $0.14 . Revenue of $24.33M (+29.2% Y/Y) beats by $2.36M . U.S. net product revenue was $17.0 million, compared to $13.4 million for the comparabl...
– U.S. Net Product Revenue Grew Approximately 27% Y/Y to $17.0 Million – – Retail Prescription Equivalents Grew 15% Y/Y; New to Brand Prescriptions Grew 56% Q/Q – – Strengthened Capital Position with $56 Million in Financing – ...
ANN ARBOR, Mich., May 04, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced today that it has retained Gibson Dunn to vindicate its contractual rights against Daiichi Sankyo Europe (“DSE”) and filed an amended complaint against DSE in the Southern District of New York. The ...
2023-05-02 19:08:00 ET Summary Esperion presented positive results for bempedoic acid in reducing major adverse cardiovascular events and heart attacks compared to a placebo, and plans to file for expanded labels this year. However, the company has been embroiled in a dispute with...
ANN ARBOR, Mich., May 01, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that Sheldon Koenig, president and chief executive officer, will participate in a fireside chat at JMP Securities Life Sciences Conference on Monday, May 15 th , 2023 at 2:00 PM ET. To register f...
ANN ARBOR, Mich., April 27, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that Sheldon Koenig, president and chief executive officer, will host a fireside chat at Bank of America Securities 2023 Health Care Conference on Thursday, May 11 th , 2023, at 11:40 AM PDT. T...
ANN ARBOR, Mich., April 25, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report first quarter 2023 financial results before the open of the U.S. financial markets on Tuesday, May 9, 2023. Following the release, company management will host a webcast at 8:00 a.m....
2023-04-19 11:34:20 ET Esperion ( NASDAQ: ESPR ) signed an agreement with Currax Pharmaceuticals which provides for all of Currax's 72 sales representatives to co-promote cholesterol lowering therapies Nexletol (bempedoic acid) and Nexlizet (bempedoic acid and ezetimibe)...
– Performance-Based Agreement Provides for Currax’s 72 Sales Representatives to Detail Esperion’s Products – – Reinforces Esperion’s Focus on Driving Persistent Growth By More Than Doubling Sales Team – ANN ARBOR...
2023-04-06 08:19:02 ET Intuitive Machines ( NASDAQ: LUNR ) +12% . Gorilla Technology Group ( GRRR ) +17% . AMC Entertainment Holdings ( AMC ) +13% stumble as court rules against conversion settlement. Esperion Therapeutics ( ESPR ) +11% ...
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...